Read this company snapshot
Daily valuation snapshot
Mustang Bio, Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.4
- Market capitalization (USD)
- $2,693,521.61
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.36
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research MBIO in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research MBIO in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing MBIO with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.4 |
| Market capitalization (USD) | $2,693,521.61 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.36 |
No matching rows. Clear the filter to see all records.
Read MBIO's valuation metrics
Company size
Mustang Bio, Inc.'s recorded market capitalization is $2,693,521.61. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
MBIO's recorded price-to-book ratio is 0.36. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Mustang Bio, Inc. with Aurora
Use the snapshot above to ask a specific question about MBIO. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow MBIO's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.